These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15450792)

  • 1. Regarding "Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind randomized study": Optimizing initial interventions.
    Farber GA; Goldberg JF
    Biol Psychiatry; 2004 Oct; 56(7):535; author reply 535-6. PubMed ID: 15450792
    [No Abstract]   [Full Text] [Related]  

  • 2. [Change in the point of view].
    Krankenpfl J; 2005; 43(1-3):23-4. PubMed ID: 15912818
    [No Abstract]   [Full Text] [Related]  

  • 3. [Duloxetine reduces pain and depression].
    Krankenpfl J; 2004; 42(7-10):246-7. PubMed ID: 15675408
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combination treatment of depression].
    Høiseth G; Solberg DK; Refsum H
    Tidsskr Nor Laegeforen; 2012 May; 132(10):1239-41. PubMed ID: 22669385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.
    Richard IH; McDermott MP; Kurlan R; Lyness JM; Como PG; Pearson N; Factor SA; Juncos J; Serrano Ramos C; Brodsky M; Manning C; Marsh L; Shulman L; Fernandez HH; Black KJ; Panisset M; Christine CW; Jiang W; Singer C; Horn S; Pfeiffer R; Rottenberg D; Slevin J; Elmer L; Press D; Hyson HC; McDonald W;
    Neurology; 2012 Apr; 78(16):1229-36. PubMed ID: 22496199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The need for clinically relevant research on treatment-resistant depression.
    Thase ME
    J Clin Psychiatry; 2001 Apr; 62(4):221-4. PubMed ID: 11379833
    [No Abstract]   [Full Text] [Related]  

  • 7. Early improvement in depressive symptoms with desvenlafaxine 50 mg/d as a predictor of treatment success in patients with major depressive disorder.
    Soares CN; Fayyad RS; Guico-Pabia CJ
    J Clin Psychopharmacol; 2014 Feb; 34(1):57-65. PubMed ID: 24346751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study.
    Nelson JC; Mazure CM; Jatlow PI; Bowers MB; Price LH
    Biol Psychiatry; 2004 Feb; 55(3):296-300. PubMed ID: 14744472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sertraline with methylphenidate in an ICU patient.
    McGlohn SE; Bostwick JM
    Psychosomatics; 1995; 36(6):584-5. PubMed ID: 7501791
    [No Abstract]   [Full Text] [Related]  

  • 10. [Duloxetine receives positive recommendation by the Scientific Committee of EMEA for treatment of depression].
    Krankenpfl J; 2004; 42(7-10):247. PubMed ID: 15675409
    [No Abstract]   [Full Text] [Related]  

  • 11. Serotonergic synergism: the risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs.
    DeBattista C; Sofuoglu M; Schatzberg AF
    Biol Psychiatry; 1998 Sep; 44(5):341-7. PubMed ID: 9755356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential physiological effects of a low dose and high doses of venlafaxine in major depression.
    Debonnel G; Saint-André E; Hébert C; de Montigny C; Lavoie N; Blier P
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):51-61. PubMed ID: 16690006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching drug class after initial SSRI failure.
    Kelsey JE
    J Clin Psychiatry; 1997 Jul; 58(7):326-7. PubMed ID: 9269258
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of dysthymia.
    Buni TM
    J Fam Pract; 1997 Jun; 44(6):528-9. PubMed ID: 9191617
    [No Abstract]   [Full Text] [Related]  

  • 15. Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder.
    Bech P; Kajdasz DK; Porsdal V
    Psychopharmacology (Berl); 2006 Oct; 188(3):273-80. PubMed ID: 16960699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled study of edivoxetine as an adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment.
    Ball S; Dellva MA; D'Souza DN; Marangell LB; Russell JM; Goldberger C
    J Affect Disord; 2014; 167():215-23. PubMed ID: 24995890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levomilnacipran (Fetzima): A New Serotonin-Norepinephrine Reuptake Inhibitor for the Treatment of Major Depressive Disorder.
    Saraceni MM; Venci JV; Gandhi MA
    J Pharm Pract; 2014 Aug; 27(4):389-95. PubMed ID: 24381243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of duloxetine on painful physical symptoms associated with depression.
    Goldstein DJ; Lu Y; Detke MJ; Hudson J; Iyengar S; Demitrack MA
    Psychosomatics; 2004; 45(1):17-28. PubMed ID: 14709757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
    Lam RW; Lönn SL; Despiégel N
    Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.
    Roose SP; Laghrissi-Thode F; Kennedy JS; Nelson JC; Bigger JT; Pollock BG; Gaffney A; Narayan M; Finkel MS; McCafferty J; Gergel I
    JAMA; 1998 Jan; 279(4):287-91. PubMed ID: 9450712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.